Back HIV/AIDS HIV/AIDS Topics HIV Treatment

AIDS 2014: What Is Needed to "Step Up the Pace" on HIV Prevention and Treatment?

"Stepping up the pace" -- the theme of AIDS 2014 -- will require a new focus on key populations and geographical concentrations of HIV, as well as intensified efforts to expand coverage of HIV testing and treatment, according to Prof. Salim Abdool Karim, director of CAPRISA, who reviewed the global state of the epidemic and treatment access at the 20th International AIDS Conference held recently in Melbourne.

alt

Read more:

AIDS 2014 HIV Treatment and Prevention Highlights [VIDEO]

Cal Cohen of the Community Research Initiative of New England sat down with HIVandHepstitis.com to offer his summary of some of the highlights of HIV treatment and prevention research presented at the 20th International AIDS Conference last month in Melbourne, Australia.

alt

Read more:

AIDS 2014: Dolutegravir Demonstrates Good Efficacy Despite Resistance

Antiretroviral regimens containing the recently approved HIV integrase inhibitor dolutegravir (Tivicay) demonstrated high rates of viral suppression even in treatment-experienced people who were resistant to NRTIs. Among people starting treatment for the first time, no resistance was detected through 96 weeks, according to study findings presented at the 20th International AIDS Conference last week in Melbourne.

alt

Read more:

AIDS 2014: Switching ART with Suppressed Viral Load Linked to Treatment Failure

People who switch away from their initial antiretroviral therapy (ART) regimen when their viral load is undetectable may have a higher likelihood of subsequent virological failure, researchers reported at the 20thInternational AIDS Conference last week in Melbourne. However, the association varied across groups and the researchers suggested their findings may reflect issues such as adherence difficulties or treatment changes due to pregnancy.

alt

Read more:

AIDS 2014 Conference Highlight from Sharon Lewin [VIDEO]

As the 20th International AIDS Conference drew to a close in Melbourne, AIDS 2014 co-chair Sharon Lewin offered an overview of some highlights of the meeting at a Friday press briefing.

alt

Read more:

Of Guidelines Targets, and Resources -- Documents that Defined AIDS 2014

If there was a phrase that defined the 20th International AIDS Conference last week in Melbourne -- one that surfaced in every few presentations and kept turning up in documents -- it was "key affected populations." New World Health Organization (WHO) guidelines released in conjunction with AIDS 2014 recommend pre-exposure prophylaxis (PrEP) as an option for gay men at risk for HIV infection and naloxone to prevent overdoses among people who inject drugs (PWID).

alt

Read more:

Coverage of the 2014 International AIDS Conference

HIVandHepatitis.com coverage of the 20th International AIDS Conference (AIDS 2014), July 20-25, in Melbourne, Australia.

Conference highlights include biomedical HIV prevention (PrEP and treatment-as-prevention), HIV cure research, interferon-free therapy for hepatitis C and HIV/HCV coinfection, access to treatment, and fighting stigma and criminalization of key affected populations.

Full listing by topic

AIDS 2014 website

7/25/14

alt